ARTA
ETRM

A.R.T. Advisors’s EnteroMedics Inc. ETRM Stock Holding History

A.R.T. Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-286
Closed -$19K – 1900
2016
Q1 		$19K Buy
+286
New +$23.1K ﹤0.01% 1317

Other funds holding ETRM

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

A.R.T. Advisors's ETRM Position: Q2 2016 in Review

A.R.T. Advisors sold out of EnteroMedics Inc. (ETRM) in Q2 2016, closing a stake of 286 shares — an estimated $19K sold.

A.R.T. Advisors first reported a position in ETRM in Q1 2016 and held it in 1 quarter. The position peaked at $19K in Q1 2016. 24 funds tracked by Wall St. Rank hold ETRM as of Q2 2016.

  • A.R.T. Advisors reported no remaining EnteroMedics Inc. position as of Q2 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 286 EnteroMedics Inc. shares in Q2 2016, an estimated $19K.
  • A.R.T. Advisors first reported a position in EnteroMedics Inc. in Q1 2016 and held it in 1 quarter.
  • A.R.T. Advisors's EnteroMedics Inc. position peaked at $19K in Q1 2016.
  • 24 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2016.

Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.